Medical Condition News

RSS

NIH panel recommends name change for polycystic ovary syndrome

An independent panel convened by the National Institutes of Health has concluded that the name of a common hormone disorder in women, polycystic ovary syndrome (PCOS), causes confusion and is a barrier to research progress and effective patient care. The current name focuses on a criterion - ovarian cysts - which is neither necessary nor sufficient to diagnose the syndrome.

24 Jan 2013

Inspiration, Ipsen and Baxter enter Asset Purchase Agreement for OBI-1

Ipsen and Inspiration Biopharmaceuticals Inc. today announced they entered into an Asset Purchase Agreement (APA) whereby Baxter International (Baxter) agrees to acquire the worldwide rights to OBI-1, a recombinant porcine factor VIII (rpFVIII) in development for congenital hemophilia A with inhibitors and acquired hemophilia A, and Ipsen's industrial facility in Milford (Boston, MA).

24 Jan 2013

New systems of classification of mental disorders may supplement diagnostic formulations

This paper introduce new systems of classification of mental disorders that may supplement diagnostic formulations. Characterizing each stage of an illness demarcates major prognostic and therapeutic differences among patients who otherwise seem to be deceptively similar since they share the same psychiatric diagnosis.

24 Jan 2013

Study may help predict which multiple myeloma patients will respond better to certain treatments

A study led by Robert G. Hawley, Ph.D., professor and chair of the department of anatomy and regenerative biology at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), may help predict which patients with multiple myeloma will respond better to certain treatments.

24 Jan 2013

UTHealth NRC to sponsor forum on sports-related concussions

Super Bowl-winning lineman turned orthopaedic surgeon Mark Adickes, M.D., is moderating a free public forum to help parents, athletes and trainers spot the warning signs of concussion.

24 Jan 2013

Normalizing p62 protein levels in immune system cells could reduce infection in CF patients

New research suggests that lowering excessive levels of a protein in immune system cells could be a strategy to clear an infection that is deadly to patients with cystic fibrosis (CF).

23 Jan 2013

Mice with reduced caloric intake accumulate longer telomeres

One of the indicators of a cell's health is the state of its DNA and containers-the chromosomes-so when these fuse together or suffer anomalies, they can become the source of illnesses like cancer and/or ageing processes.

23 Jan 2013

Hyperbaric treatment restores neurological function in damaged brains

Stroke, traumatic injury, and metabolic disorder are major causes of brain damage and permanent disabilities, including motor dysfunction, psychological disorders, memory loss, and more. Current therapy and rehab programs aim to help patients heal, but they often have limited success.

23 Jan 2013

Researcher presents proposals designed to address affective-sexual diversity in school environments

How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.

23 Jan 2013

DFG now extends funding for research on immunological therapy at Charité

The DFG (Deutsche Forschungsgemeinschaft) has now extended the funding of a research association which is located at the Charité - Universitätsmedizin Berlin. The Collaborative Research Centre (SFB) will receive funding in excess of ten million Euros over the next four years.

23 Jan 2013

MD Anderson - Orlando first in Central Florida to offer pilot lung cancer screening program

One year after MD Anderson Cancer Center Orlando launched a pilot lung cancer screening program for patients most at risk for developing the disease, such screenings are now being recommended by the American Cancer Society.

23 Jan 2013

World Cancer Day to focus on awareness and prevention, importance of research

Cancer takes the lives of some 7.6 million people worldwide each year, according to the World Health Organization. And while the upcoming World Cancer Day will focus on a global message of cancer awareness and prevention, the importance of cancer research also will resonate.

23 Jan 2013

Study identifies how astrocytes regulate a neurotransmitter involved in sleep

Neuroscience researchers from Tufts University have found that our star-shaped brain cells, called astrocytes, may be responsible for the rapid improvement in mood in depressed patients after acute sleep deprivation. This in vivo study, published in the current issue of Translational Psychiatry, identified how astrocytes regulate a neurotransmitter involved in sleep.

23 Jan 2013

BH3-mimetics might be new option for treatment of autoimmune conditions

Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur when the immune system attacks the body's own tissues.

23 Jan 2013

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved a new use of Avastin (bevacizumab) in combination with fluoropyrimidine-based irinotecan or oxaliplatin chemotherapy for people with metastatic colorectal cancer (mCRC).

23 Jan 2013

Salk Institute to establish Helmsley Center for Genomic Medicine

The Salk Institute for Biological Studies has received a $42 million gift-the largest in the Institute's history-to establish the Helmsley Center for Genomic Medicine (HCGM), a research center dedicated to decoding the common genetic factors underlying many complex chronic human diseases.

23 Jan 2013

Novartis receives FDA approval for Exjade to treat chronic iron overload in NTDT patients

The U.S. Food and Drug Administration today expanded the approved use of Exjade (deferasirox) to treat patients ages 10 years and older who have chronic iron overload resulting from a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).

23 Jan 2013

Article analyzes role of nutrition in mood swings

In this study, preliminary data yields conflicting but mainly positive evidence for the use of n-3 fatty acids and chromium in the treatment of bipolar depression. Limited evidence found that inositol may be helpful for bipolar depression, but larger sample sizes are needed. Preliminary randomized, controlled trials suggest that choline, magnesium, folate and tryptophan may be beneficial for reducing symptoms of mania.

23 Jan 2013

Data from Provectus' PV-10 pre-clinical study on melanoma to be presented at AACR meeting

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data on PV-10 will be presented in a poster presentation at the American Association for Cancer Research Annual Meeting in Washington, DC.

23 Jan 2013

Actavis seeks FDA approval to market generic Opana ER

Watson Pharmaceuticals, Inc. today confirmed that Actavis South Atlantic LLC, which was acquired by Watson in October, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Oxymorphone Hydrochloride Extended-release Tablets.

23 Jan 2013

Medical Condition News

NIH panel recommends name change for polycystic ovary syndrome

Inspiration, Ipsen and Baxter enter Asset Purchase Agreement for OBI-1

New systems of classification of mental disorders may supplement diagnostic formulations

Study may help predict which multiple myeloma patients will respond better to certain treatments

UTHealth NRC to sponsor forum on sports-related concussions

Normalizing p62 protein levels in immune system cells could reduce infection in CF patients

Mice with reduced caloric intake accumulate longer telomeres

Hyperbaric treatment restores neurological function in damaged brains

Researcher presents proposals designed to address affective-sexual diversity in school environments

DFG now extends funding for research on immunological therapy at Charité

MD Anderson - Orlando first in Central Florida to offer pilot lung cancer screening program

World Cancer Day to focus on awareness and prevention, importance of research

Study identifies how astrocytes regulate a neurotransmitter involved in sleep

BH3-mimetics might be new option for treatment of autoimmune conditions

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Salk Institute to establish Helmsley Center for Genomic Medicine

Novartis receives FDA approval for Exjade to treat chronic iron overload in NTDT patients

Article analyzes role of nutrition in mood swings

Data from Provectus' PV-10 pre-clinical study on melanoma to be presented at AACR meeting

Actavis seeks FDA approval to market generic Opana ER

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News